Clinical Trial Update: Broncho-Vaxom (OM 85 BV) in Children Suffering From Atopic Dermatitis [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating Broncho-Vaxom (OM-85 BV) in children with atopic dermatitis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atopic Dermatitis

Drugs mentioned

• Broncho-Vaxom (OM-85)

Snippet

Sponsor: Vifor Pharma | Conditions: Atopic Dermatitis | Phase 3 | Status: COMPLETED